miRecule
Pre-clinicalmiRecule™ is a biotechnology company developing RNA therapies for cancer and muscular dystrophy. Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics designed to help patients live a life free from the debilitating symptoms of their disorders.
Founded
2024
Focus
RNA & Gene Therapy
About
miRecule™ is a biotechnology company developing RNA therapies for cancer and muscular dystrophy. Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics designed to help patients live a life free from the debilitating symptoms of their disorders.
Funding History
3Total raised: $14.7M
Grant$500KCystic Fibrosis FoundationMar 15, 2022
Series A$10MAlexandria Venture InvestmentsOct 15, 2021
Seed$4.2MAlexandria Venture InvestmentsAug 15, 2020
Company Info
TypePrivate
Founded2024
LocationGaithersburg, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile